Literature DB >> 12815153

Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

Philip N Hawkins, Helen J Lachmann, Michael F McDermott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12815153     DOI： 10.1056/NEJM200306193482523

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  133 in total

1.  Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.

Authors:  Cailin H Sibley; Nikki Plass; Joseph Snow; Edythe A Wiggs; Carmen C Brewer; Kelly A King; Christopher Zalewski; H Jeffrey Kim; Rachel Bishop; Suvimol Hill; Scott M Paul; Patrick Kicker; Zachary Phillips; Joseph G Dolan; Brigitte Widemann; Nalini Jayaprakash; Frank Pucino; Deborah L Stone; Dawn Chapelle; Christopher Snyder; John A Butman; Robert Wesley; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2012-07

Review 2.  Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors:  C A Dinarello
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

Review 3.  Inflammasome-mediated autoinflammatory disorders.

Authors:  Shruti P Wilson; Suzanne L Cassel
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

4.  Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis.

Authors:  David C Wilson; Anthony D Marinov; Harry C Blair; Daniel S Bushnell; Susan D Thompson; Yury Chaly; Raphael Hirsch
Journal:  Arthritis Rheum       Date:  2010-08

Review 5.  Autoinflammatory Syndromes in Children.

Authors:  Ruth J Pepper; Helen J Lachmann
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

6.  Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis.

Authors:  Celine A Beamer; Benjamin P Seaver; David M Shepherd
Journal:  Toxicol Sci       Date:  2012-01-23       Impact factor: 4.849

Review 7.  IL-1 pathways in inflammation and human diseases.

Authors:  Cem Gabay; Céline Lamacchia; Gaby Palmer
Journal:  Nat Rev Rheumatol       Date:  2010-02-23       Impact factor: 20.543

Review 8.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

9.  Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts.

Authors:  James E Balow; John G Ryan; Jae Jin Chae; Matthew G Booty; Ariel Bulua; Deborah Stone; Hong-Wei Sun; James Greene; Beverly Barham; Raphaela Goldbach-Mansky; Daniel L Kastner; Ivona Aksentijevich
Journal:  Ann Rheum Dis       Date:  2012-12-05       Impact factor: 19.103

10.  Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease.

Authors:  Yelda Bilginer; Nuray Aktay Ayaz; Seza Ozen
Journal:  Clin Rheumatol       Date:  2009-09-23       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.